1. TEX264 in DNA replication and genome stability
- Author
-
Fielden, John Christopher and Ramadan, Kristijan
- Subjects
616.99 ,Oncology - Abstract
DNA damage drives numerous human pathologies, including cancer and ageing. However, it can also be exploited in cancer therapy, where most chemotherapeutics exert their effects by inducing DNA damage. A common type of DNA lesion induced by chemotherapeutics is DNA-protein crosslinks (DPC). DPCs are also very common endogenous DNA lesions which impede DNA replication, transcription, and mitosis. However, very little is known about the mechanisms by which they are repaired. Our laboratory recently characterised a genetic syndrome, known as Ruijs-Aalfs syndrome (RJALS), characterised by premature ageing and early onset hepatocellular carcinoma, caused by mutations in the SPRTN gene. This thesis contributes to the characterisation of SPRTN as an essential DPC repair protease that promotes DNA replication progression. We identify topoisomerase 1 cleavage complexes (TOP1cc) as SPRTN substrates. TOP1ccs are composed of the enzyme, TOP1, covalently bound to DNA. TOP1ccs are highly cytotoxic endogenous lesions which can also be induced by the frontline class of anti-cancer drugs known as camptothecins. In addition, we identify the previously uncharacterised protein, testes expressed 264 (TEX264), as being critical for TOP1cc repair. TEX264 recognises unmodified and SUMO1-modified TOP1 and promotes TOP1cc repair by recruiting p97 and SPRTN. Thus, TEX264 promotes DNA replication fork progression and preserves genome stability. Furthermore, this study identifies SPRTN as a biomarker of clinical resistance to the camptothecin derivative, irinotecan, in patients with metastatic colorectal cancer.
- Published
- 2020